Lisata Therapeutics, Inc. (LSTA)
LSTA Stock Price Chart
Explore Lisata Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze LSTA price movements and trends.
LSTA Company Profile
Discover essential business fundamentals and corporate details for Lisata Therapeutics, Inc. (LSTA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Mar 1999
Employees
26.00
Website
https://www.lisata.comCEO
David J. Mazzo
Description
Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
LSTA Financial Timeline
Browse a chronological timeline of Lisata Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.59.
Earnings released on 7 Aug 2025
EPS came in at -$0.54 surpassing the estimated -$0.65 by +16.92%, while revenue for the quarter reached $70.00K .
Earnings released on 8 May 2025
EPS came in at -$0.55 falling short of the estimated -$0.53 by -3.77%.
Earnings released on 27 Feb 2025
EPS came in at -$0.55 surpassing the estimated -$0.76 by +27.63%, while revenue for the quarter reached $1.00M .
Earnings released on 12 Nov 2024
EPS came in at -$0.59 surpassing the estimated -$0.75 by +21.33%.
Earnings released on 12 Aug 2024
EPS came in at -$0.61 surpassing the estimated -$0.75 by +18.67%.
Earnings released on 9 May 2024
EPS came in at -$0.65 surpassing the estimated -$0.73 by +10.96%.
Earnings released on 29 Feb 2024
EPS came in at -$0.66 surpassing the estimated -$0.86 by +23.26%.
Earnings released on 2 Nov 2023
EPS came in at -$0.65 surpassing the estimated -$0.93 by +30.11%.
Earnings released on 14 Aug 2023
EPS came in at -$0.50 surpassing the estimated -$0.70 by +28.57%.
Earnings released on 9 May 2023
EPS came in at -$0.77 surpassing the estimated -$0.81 by +4.94%.
Earnings released on 30 Mar 2023
EPS came in at -$0.76 surpassing the estimated -$0.96 by +20.83%, while revenue for the quarter reached $121.37M .
Earnings released on 10 Nov 2022
EPS came in at -$1.47 falling short of the estimated -$0.90 by -63.33%.
Stock split effective on 15 Sept 2022
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 4 Aug 2022
EPS came in at -$1.65 falling short of the estimated -$1.45 by -13.79%.
Earnings released on 5 May 2022
EPS came in at -$1.05 surpassing the estimated -$1.45 by +27.59%.
Earnings released on 22 Mar 2022
EPS came in at -$1.65 surpassing the estimated -$2.17 by +23.96%.
Earnings released on 4 Nov 2021
EPS came in at -$1.80 surpassing the estimated -$2.25 by +20.00%.
Earnings released on 5 Aug 2021
EPS came in at -$1.50 surpassing the estimated -$2.17 by +30.88%.
Earnings released on 6 May 2021
EPS came in at -$2.85 falling short of the estimated -$1.27 by -124.41%.
Earnings released on 25 Feb 2021
EPS came in at -$4.20 falling short of the estimated -$3.80 by -10.53%.
Earnings released on 5 Nov 2020
EPS came in at -$4.35 matching the estimated -$4.35.
LSTA Stock Performance
Access detailed LSTA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.